| | NETWORK: N00364 | |
Entry |
|
Name |
HPV E5 to antigen processing and presentation by MHC class I molecules
|
Definition |
E5 -| (MHCI+BCAP31) |
Expanded |
K21812 -| ((3105,3106,3107,3133,3134,3135)+10134) |
Class |
|
Type |
Pathogen
|
Pathway |
|
Disease |
|
Gene |
3105 | HLA-A; major histocompatibility complex, class I, A |
3106 | HLA-B; major histocompatibility complex, class I, B |
3107 | HLA-C; major histocompatibility complex, class I, C |
3133 | HLA-E; major histocompatibility complex, class I, E |
3134 | HLA-F; major histocompatibility complex, class I, F |
3135 | HLA-G; major histocompatibility complex, class I, G |
10134 | BCAP31; B cell receptor associated protein 31 |
|
Perturbant |
K21812 (E5) | E5; HPV protein E5 |
|
Reference |
|
Authors |
Moody CA, Laimins LA |
Title |
Human papillomavirus oncoproteins: pathways to transformation. |
Journal |
|
Reference |
|
Authors |
Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J |
Title |
Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes. |
Journal |
|
Reference |
|
Authors |
Tummers B, Burg SH |
Title |
High-risk human papillomavirus targets crossroads in immune signaling. |
Journal |
|
LinkDB |
|
|
|